57 related articles for article (PubMed ID: 26390704)
1. Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer.
Ling S; Ruiqin M; Guohong Z; Ying W
Eur J Gynaecol Oncol; 2015; 36(4):463-8. PubMed ID: 26390704
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.
Xu Y; Hu J; Zhang C; Liu Y
Mol Med Rep; 2017 Dec; 16(6):8530-8536. PubMed ID: 28990044
[TBL] [Abstract][Full Text] [Related]
3. circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.
Liu S; Yuan L; Li J; Liu Y; Wang H; Ren X
Ann Med; 2023 Dec; 55(1):908-919. PubMed ID: 36896567
[TBL] [Abstract][Full Text] [Related]
4. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.
Yuan J; Wang K; Xi M
Med Sci Monit; 2016 Feb; 22():617-24. PubMed ID: 26908019
[TBL] [Abstract][Full Text] [Related]
5. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.
Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A
PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777
[TBL] [Abstract][Full Text] [Related]
6. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract][Full Text] [Related]
7. Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).
Scalici JM; Arapovic S; Saks EJ; Atkins KA; Petroni G; Duska LR; Slack-Davis JK
Cancer; 2017 May; 123(6):977-984. PubMed ID: 28263384
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.
Wen N; Wang Y; Wen L; Zhao SH; Ai ZH; Wang Y; Wu B; Lu HX; Yang H; Liu WC; Li Y
J Transl Med; 2014 May; 12():134. PubMed ID: 24885308
[TBL] [Abstract][Full Text] [Related]
9. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract][Full Text] [Related]
10. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PD; ; ; ; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; deFazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1421-7. PubMed ID: 24740199
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.
Minareci Y; Ak N; Sozen H; Tosun OA; Kucukgergin C; Aydin F; Bingul İ; Salihoglu MY; Topuz S
Mol Biol Rep; 2024 Apr; 51(1):515. PubMed ID: 38622482
[TBL] [Abstract][Full Text] [Related]
12. Expression of preoperative KISS1 gene in tumor tissue with epithelial ovarian cancer and its prognostic value.
Cao F; Chen L; Liu M; Lin W; Ji J; You J; Qiao F; Liu H
Medicine (Baltimore); 2016 Nov; 95(46):e5296. PubMed ID: 27861355
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
[TBL] [Abstract][Full Text] [Related]
14. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.
Tan TZ; Miow QH; Huang RY; Wong MK; Ye J; Lau JA; Wu MC; Bin Abdul Hadi LH; Soong R; Choolani M; Davidson B; Nesland JM; Wang LZ; Matsumura N; Mandai M; Konishi I; Goh BC; Chang JT; Thiery JP; Mori S
EMBO Mol Med; 2013 Jul; 5(7):1051-66. PubMed ID: 23666744
[TBL] [Abstract][Full Text] [Related]
15. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
Biotechnol Appl Biochem; 2024 Mar; ():. PubMed ID: 38494670
[TBL] [Abstract][Full Text] [Related]
16. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.
Sucheston-Campbell LE; Cannioto R; Clay AI; Etter JL; Eng KH; Liu S; Battaglia S; Hu Q; Szender JB; Minlikeeva A; Joseph JM; Mayor P; Abrams SI; Segal BH; Wallace PK; Soh KT; Zsiros E; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Bjorge L; Bruegl A; Campbell IG; Campbell SP; Chenevix-Trench G; Cramer DW; Dansonka-Mieszkowska A; Dao F; Diergaarde B; Doerk T; Doherty JA; du Bois A; Eccles D; Engelholm SA; Fasching PA; Gayther SA; Gentry-Maharaj A; Glasspool RM; Goodman MT; Gronwald J; Harter P; Hein A; Heitz F; Hillemmanns P; Høgdall C; Høgdall EV; Huzarski T; Jensen A; Johnatty SE; Jung A; Karlan BY; Klapdor R; Kluz T; Konopka B; Kjær SK; Kupryjanczyk J; Lambrechts D; Lester J; Lubiński J; Levine DA; Lundvall L; McGuire V; McNeish IA; Menon U; Modugno F; Ness RB; Orsulic S; Paul J; Pearce CL; Pejovic T; Pharoah P; Ramus SJ; Rothstein J; Rossing MA; Rübner M; Schildkraut JM; Schmalfeldt B; Schwaab I; Siddiqui N; Sieh W; Sobiczewski P; Song H; Terry KL; Van Nieuwenhuysen E; Vanderstichele A; Vergote I; Walsh CS; Webb PM; Wentzensen N; Whittemore AS; Wu AH; Ziogas A; Odunsi K; Chang-Claude J; Goode EL; Moysich KB;
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):420-424. PubMed ID: 27677730
[No Abstract] [Full Text] [Related]
17. The polymorphism rs4705342 in the promoter of miR-143/145 is related to the risk of epithelial ovarian cancer and patient prognosis.
Zhao J; Zuo W; Zhang Y; He C; Zhao W; Meng T
Front Oncol; 2023; 13():1122284. PubMed ID: 37081985
[TBL] [Abstract][Full Text] [Related]
18. Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.
Weidle UH; Birzele F; Kollmorgen G; Nopora A
Cancer Genomics Proteomics; 2018; 15(1):1-15. PubMed ID: 29275359
[TBL] [Abstract][Full Text] [Related]
19. Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line.
Blayney JK; Davison T; McCabe N; Walker S; Keating K; Delaney T; Greenan C; Williams AR; McCluggage WG; Capes-Davis A; Harkin DP; Gourley C; Kennedy RD
Nucleic Acids Res; 2016 Sep; 44(17):e137. PubMed ID: 27353327
[TBL] [Abstract][Full Text] [Related]
20. Identifying Serum Small Extracellular Vesicle MicroRNA as a Noninvasive Diagnostic and Prognostic Biomarker for Ovarian Cancer.
Li L; Zhang F; Zhang J; Shi X; Wu H; Chao X; Ma S; Lang J; Wu M; Zhang D; Liang Z
ACS Nano; 2023 Oct; 17(19):19197-19210. PubMed ID: 37750402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
